Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Non-cash Items (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Non-cash Items for 7 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 83.87% to $3.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, up 83.87% year-over-year, with the annual reading at $3.3 million for FY2025, 83.87% up from the prior year.
  • Non-cash Items for Q4 2025 was $3.3 million at Whitehawk Therapeutics, up from $539000.0 in the prior quarter.
  • The five-year high for Non-cash Items was $10.0 million in Q4 2021, with the low at $459000.0 in Q2 2025.
  • Average Non-cash Items over 4 years is $3.2 million, with a median of $2.6 million recorded in 2021.
  • Peak annual rise in Non-cash Items hit 12451.61% in 2021, while the deepest fall reached 96.45% in 2021.
  • Over 4 years, Non-cash Items stood at $10.0 million in 2021, then crashed by 43.72% to $5.6 million in 2022, then plummeted by 67.72% to $1.8 million in 2024, then soared by 83.87% to $3.3 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $3.3 million, $539000.0, and $459000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.